Abscopal Effect After Localized Radiotherapy in a Patient With Sezary Syndrome Under Treatment with Mogamulizumab

Vieri Grandi; Isabella Ciardetti; Andrea Gemignani; Eleonora Gherardi; Tommaso Grassi; Nicola Pimpinelli

doi:10.5826/dpc.1304a227

Abscopal Effect After Localized Radiotherapy in a Patient With Sezary Syndrome Under Treatment with Mogamulizumab

Authors

Vieri Grandi Department of Health Sciences, Section of Dermatology, University of Florence, P. Palagi Hospital, Florence, Italy
Isabella Ciardetti Department of Health Sciences, Section of Dermatology, University of Florence, P. Palagi Hospital, Florence, Italy
Andrea Gemignani Department of Health Sciences, Section of Dermatology, University of Florence, P. Palagi Hospital, Florence, Italy
Eleonora Gherardi Department of Health Sciences, Section of Dermatology, University of Florence, P. Palagi Hospital, Florence, Italy
Tommaso Grassi Public Health, Hygiene and Preventive Medicine Unit, P. Palagi Hospital, Florence, Italy
Nicola Pimpinelli Department of Health Sciences, Section of Dermatology, University of Florence, P. Palagi Hospital, Florence, Italy

References

Yilmaz MT, Elmali A, Yazici G. Abscopal Effect, From Myth to Reality: From Radiation Oncologists’ Perspective. Cureus 2019;11:e3860.

Kim YH, Bagot M, Pinter-Brown L, et al. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol 2018;19:1192–204.

Downloads

Published

2023-10-31

Issue

2023 Vol 13, No 4 | October

Section

Image Letter

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

How to Cite

Grandi V, Ciardetti I, Gemignani A, Gherardi E, Grassi T, Pimpinelli N. Abscopal Effect After Localized Radiotherapy in a Patient With Sezary Syndrome Under Treatment with Mogamulizumab. Dermatol Pract Concept. 2023;13(4):e2023227. doi:10.5826/dpc.1304a227